Royal Bank of Canada’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Sell |
69
-1,046
| -94% | – | ﹤0.01% | 6869 |
|
2025
Q1 | $1K | Sell |
1,115
-1,110
| -50% | -$996 | ﹤0.01% | 6333 |
|
2024
Q4 | $7K | Sell |
2,225
-10,118
| -82% | -$31.8K | ﹤0.01% | 5964 |
|
2024
Q3 | $62K | Buy |
12,343
+8,732
| +242% | +$43.9K | ﹤0.01% | 5138 |
|
2024
Q2 | $21K | Buy |
+3,611
| New | +$21K | ﹤0.01% | 5674 |
|
2022
Q4 | – | Sell |
-184
| Closed | -$1K | – | 7147 |
|
2022
Q3 | $1K | Buy |
+184
| New | +$1K | ﹤0.01% | 6780 |
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$3K | – | 7130 |
|
2022
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6915 |
|
2021
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 6693 |
|
2021
Q3 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 6509 |
|